The FDA accepted Bayer's sNDA and granted Priority Review to elinzanetant for vasomotor symptoms in women on endocrine therapy for HR+ breast cancer.
|Articles|September 15, 2002
Stethoscope Helps Hard-of-Hearing Patients
Lend a stethoscope to hard-of-hearing patients who are not wearing a hearing aid. Speak directly into the stethoscope diaphragm, and the patient may hear well enough to communicate with you. Be sure to clean the stethoscope's ear tips before and after the patient uses it.
Advertisement
Lend a stethoscope to hard-of-hearingpatients who are not wearing a hearingaid. Speak directly into the stethoscopediaphragm, and the patientmay hear well enough to communicatewith you. Be sure to clean thestethoscope's ear tips before and afterthe patient uses it.
- Bill Demshok, PA-C, MS
Miami
Advertisement
Related to this article
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Lumateperone reduced acute mania symptoms by day 3 in a phase 3 bipolar 1 trial, according to Johnson & Johnson.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata
2
Detecting Atrial Fibrillation in Primary Care: Warning Signs and Modifiable Risk Factors
3
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
4
Beyond Semaglutide and Tirzepatide: The Next Wave of Obesity Medicines
5